FANJ
IGC icon

Financial Architects (New Jersey)’s IGC Pharma IGC Stock Holding History

Financial Architects (New Jersey)’s Portfolio IGC Stock Details IGC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-1,250
Closed -$3K – 1327
2019
Q1 		$3K Buy
+1,250
New +$2.84K ﹤0.01% 1287
2018
Q4 		– Sell
-1,000
Closed -$6K – 1402
2018
Q3 		$6K Buy
+1,000
New +$1.04K ﹤0.01% 1198

Other funds holding IGC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CFA
Carroll Financial Associates Charlotte, North Carolina $1.88B AUM 20.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DP
Dearborn Partners Chicago, Illinois $1.85B AUM 6.59% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Financial Architects (New Jersey)'s IGC Position: Q2 2019 in Review

Financial Architects (New Jersey) sold out of IGC Pharma (IGC) in Q2 2019, closing a stake of 1,250 shares — an estimated $3K sold.

Financial Architects (New Jersey) first reported a position in IGC in Q3 2018 and held it in 2 quarters. The position peaked at $6K in Q3 2018. 31 funds tracked by Wall St. Rank hold IGC as of Q2 2019.

  • Financial Architects (New Jersey) reported no remaining IGC Pharma position as of Q2 2019 after selling out during the quarter.
  • Financial Architects (New Jersey) sold 1,250 IGC Pharma shares in Q2 2019, an estimated $3K.
  • Financial Architects (New Jersey) first reported a position in IGC Pharma in Q3 2018 and held it in 2 quarters.
  • Financial Architects (New Jersey)'s IGC Pharma position peaked at $6K in Q3 2018.
  • 31 funds tracked by Wall St. Rank held IGC Pharma as of Q2 2019.

Based on Financial Architects (New Jersey)'s 13F filing for Q2 2019, filed 14 Aug 2019.